TIPARP and breast carcinoma: Together, these results identify PARP7 as a tumor-intrinsic brake on radiation-induced innate immune activation and demonstrate that PARP7 inhibition amplifies RT-driven type I IFN and necroptotic responses across diverse breast cancer models.